California AG Serves OpenAI Investigative Subpoena as Part of Ongoing Investigation

October 5 - ** Shares of pharmaceutical company Insmed (INSM.O) fell more than 3% in pre-market trading to $107.59. ** Sara Bonstein will resign from her position as Chief Financial Officer, effective October 30. ** Sara will stay on until the end of this month to ensure a smooth transition during the company's release of its Q3 financial results on October 29. ** Before joining Insmed, Sara served as Chief Financial Officer at OncoSec Medical. ** The company reaffirmed its fiscal 2026 performance guidance and has begun the search for the next Chief Financial Officer. ** All 25 brokerages covering the stock remain bullish; the median target price is compiled by LSEG data. ** As of the close of the previous trading day, the stock was down 36.15% year-to-date. (To assist non-English speakers, Reuters automatically translates its reports into several other languages. Because automated translations may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text and provides automated translation solely for reader convenience. Reuters accepts no liability for any damage or losses caused by the use of automated translation functionality.)

October 5 - Shares of transportation brokerage RXO (RXO.O) rose 21.6% in pre-market trading to $28.4 after freight forwarding company C.H. Robinson Worldwide (CHRW.O) announced it will acquire RXO in a $5.8 billion cash and stock deal. CHRW shares fell 7.7% to $145.5. Under the terms of the deal, RXO shareholders will receive $17.25 in cash and 0.0856 shares of CHRW common stock for each RXO share held. The transaction is expected to close in the first half of 2027, pending regulatory and RXO shareholder approval. As of the previous trading day’s close, RXO shares had risen 85% year-to-date, while CHRW shares were down 1.9% year-to-date.

October 5 – Shares of motorcycle manufacturer Harley-Davidson (HOG.N) rose 3.9% in pre-market trading to $25.50 after Citigroup upgraded its rating from "Neutral" to "Buy". "There was only a slight improvement in retail business in early 2026, but now momentum appears to be increasing; 2027 is expected to benefit from the launch of major new products, significant cost-saving measures, and potential earnings upside from LiveWire," said Citigroup. Citigroup indicated that the current stock price level before the release of Q3 earnings and guidance is a very attractive entry point for buying. The broker raised its price target from $31 to $33. Out of 17 brokers, 6 rate the stock as "Buy" or higher, 8 with a "Hold" rating, and 3 with a "Sell" rating; the median price target is $30, according to data compiled by LSEG. The stock currently trades at 14.71 times forecasted earnings per share for the next 12 months, well above the industry median of 8.41 times. As of the previous trading day’s close, HOG has gained 19.8% year-to-date.

On October 5, shares of prison operator GEO Group (GEO.N) rose 4.8% in pre-market trading to $32.9. The company will sell its ICE processing center complex in Adelanto, California, for $950 million. GEO expects to receive approximately $705 million in net proceeds from the sale after taxes and other fees. The company plans to use the proceeds and future cash flows to reduce debt and repurchase shares. The board has increased the share repurchase authorization by $750 million, bringing the total to $1.25 billion. As of the last close, the stock had gained 94.5% year-to-date. (For the convenience of non-English speakers, Reuters automates its reports into several other languages. As automated translation may have errors or lack context, Reuters does not guarantee the accuracy of the automated translation and provides it only for the convenience of readers. Reuters assumes no responsibility for any damage or loss caused by the use of the automated translation feature.)